Class I Beef Recall due to E. coli Contamination
West Missouri Beef, LLC has voluntarily recalled 14,000 pounds of boneless beef products due to potential contamination by E. coli O157:H7. USDA's Food Safety and Inspection Service (FSIS) announced the Class I recall in a press release last night. It is the third Class I recall this year, and the fifth since November, adding up to 1,636,000 pounds of beef products that have been recalled due to potential E. coli O157:H7 contamination in the last 3+ months.
What is a Class I recall?
A Class I recall, according to FDA definitions, should occur when "there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death." Class II and III recalls are appropriate only when there is a significantly lesser, or remote, risk of adverse health consequences, or when the health consequences are minor. Due to its lethal capacity, E. coli O157:H7 is a bacteria that always requires a Class I recall.
What is E. coli O157:H7?
Escherichia coli (E. coli) are members of a large group of bacterial germs that inhabit the intestinal tract of humans and other warm blooded animals (mammals, birds). Newborns have a sterile alimentary tract which within two days becomes colonized with E. coli.
More than 700 serotypes of E. coli have been identified. The different E. coli serotypes are distinguished by their “O” and “H” antigens on their bodies and flagella, respectively. The E. coli serotypes that are responsible for the numerous reports of contaminated foods and beverages are those that produce Shiga toxin (Stx), so called because the toxin is virtually identical to that produced by another bacteria known as Shigella dysenteria type 1 (that also causes bloody diarrhea and hemolytic uremic syndrome [HUS] in emerging countries like Bangladesh) (Griffin & Tauxe, 1991, p. 60, 73). The best known and most notorious Stx-producing E. coli is E. coli O157:H7. It is important to remember that most kinds of E. coli bacteria do not cause disease in humans, indeed, some are beneficial, and some cause infections other than gastrointestinal infections, such urinary tract infections. This section deals specifically with Stx-producing E. coli, including specifically E. coli O157:H7.
Shiga toxin is one of the most potent toxins known to man, so much so that the Centers for Disease Control and Prevention (CDC) lists it as a potential bioterrorist agent (CDC, n.d.). It seems likely that DNA from Shiga toxin-producing Shigella bacteria was transferred by a bacteriophage (a virus that infects bacteria) to otherwise harmless E. coli bacteria, thereby providing them with the genetic material to produce Shiga toxin.
Although E. coli O157:H7 is responsible for the majority of human illnesses attributed to E. coli, there are additional Stx-producing E. coli (e.g., E. coli O121:H19) that can also cause hemorrhagic colitis and post-diarrheal hemolytic uremic syndrome (D+HUS). HUS is a syndrome that is defined by the trilogy of hemolytic anemia (destruction of red blood cells), thrombocytopenia (low platelet count), and acute kidney failure.
Stx-producing E. coli organisms have several characteristics that make them so dangerous. They are hardy organisms that can survive several weeks on surfaces such as counter tops, and up to a year in some materials like compost. They have a very low infectious dose meaning that only a relatively small number of bacteria, less than 50, are needed “to set-up housekeeping” in a victim’s intestinal tract and cause infection.
The Centers for Disease Control and Prevention (CDC) estimates that every year at least 2000 Americans are hospitalized, and about 60 die as a direct result of E. coli infections and its complications. A recent study estimated the annual cost of E. coli O157:H7 illnesses to be $405 million (in 2003 dollars) which included $370 million for premature deaths, $30 million for medical care, and $5 million for lost productivity (Frenzen, Drake, and Angulo, 2005).
What is Hemolytic Uremic Syndrome?
Post-diarrheal Hemolytic Uremic Syndrome (D+HUS) is a severe, life-threatening complication that occurs in about 10% of those infected with E. coli O157:H7 or other Shiga toxin (Stx) producing E. coli. D+HUS was first described in 1955, but was not known to be secondary to E. coli infections until 1982. It is now recognized as the most common cause of acute kidney failure in infants and young children. Adolescents and adults are also susceptible, as are the elderly who often succumb to the disease.
How did these otherwise harmless E. coli become such killers? It seems likely that DNA from a Shiga toxin producing bacterium known as Shigella dysenteriae type 1 was transferred by a bacteriophage (bacteria infected with a virus) to harmless E. coli bacteria, thereby providing them with the genes to produce one of the most potent toxins known to man. So potent, that the Department of Homeland Security lists it as a potential bioterrorist agent. Although E. coli O157:H7 are responsible for the majority of cases in America, there are many additional Stx producing E. coli that can cause D+ HUS.
The chain of events leading to HUS begins with ingestion of Stx producing E. coli (e.g., E. coli O157: H7) in contaminated food, beverages or through person to person transmission. These E. coli rapidly multiply in the intestines causing colitis (diarrhea), and tightly bind to cells that line the large intestine. This snug attachment facilitates absorption of the toxin into the circulation where it becomes attached to weak receptors on white blood cells (WBC) thus allowing the toxin to “ride piggyback” to the kidneys where it is transferred to numerous avid (strong) Gb3 receptors that grasp and hold on to the toxin. Organ injury is primarily a function of Gb3 receptor location and density. Receptors are probably heterogeneously distributed in the major body organs, and this may explain why some patients develop injury in other organs (e.g., brain, pancreas).
Once Stx attaches to receptors, it moves into the cell’s cytoplasm where it shuts down the cells’ protein machinery resulting in cellular injury and/or death. This cellular injury activates blood platelets and the coagulation cascade which results in the formation of clots in the very small vessels of the kidney resulting in acute kidney injury and failure. The red blood cells are hemolyized (destroyed) by Stx and/or damaged as they attempt to pass through partially obstructed microvessels. Blood platelets (required for normal blood clotting), are trapped in the tiny blood clots or are damaged and destroyed by the spleen.
As the newly appointed deputy commissioner for food safety at the FDA, Michael Taylor has a lot on his plate. Many different things to accomplish, not least of which a ramped up, more proactive approach to food safety within the agencies of government. Perhaps the creation of a unified governmental body for all things food safety? Maybe giving the USDA and FDA the legal authority to recall products themselves, rather than rely on conflicted food manufacturing companies to do it themselves when they learn about a problem. Stiffer penalties, including personal liability, for reckless or willful corporate conduct that ends up causing an outbreak?
On Tuesday, the FDA certainly took a step in the right direction by implementing the Reportable Food Registry, under federal regulations codified at
ABC News
For the third time this year, the U.S. Food & Drug Administration (FDA) is carefully orchestrating a “voluntary recall” of all products containing a certain ingredient.
Chairman Henry Waxman, D-CA, says the full committee will likely vote the measure out to the House floor next Wednesday.
The House Energy and Commerce Committee is out with a discussion draft of “the Food Safety Enhancement Act of 2009.”
In the piece, the authors promote bringing regulated industries, patient and consumer groups, and others to the table to discuss solutions to approval delays and safety issues. They wrote, “We expect to collaborate with other federal agencies and outside partners to address problems that the agency cannot solve alone.” Consumer groups such as
In a bit of news that is less surprising than it should be, the AP today reports that the FDA has for the last several years failed to perform a large percentage of required audits for inspections being conducted (under contract) by the States. According to today's report (based on documents recently released to Congress:.jpg)
Munsell said that judging from the comments his survey elicited, inspectors appear to be as frustrated about the situation as small-plant operators. "Meat-inspection personnel are throwing their hands into the air, as they again are being forced to implement policy, which was stillborn before it left Washington, D.C.," he told M&P. "The OPEER office in FSIS is totally closed to new suggestions, and bulldozes ahead with no semblance of common sense or scientific underpinnings. Agency field personnel must quietly acquiesce to these inane demands, or face diminished career advancement and/or reassignment to remote locations without family."
Neither the FDA nor the USDA had the authority to order ConAgra to recall the products. In fact, all food recalls, except for those involving infant formula, are voluntary. Often, the government gets a product recalled by warning the company it could face bad publicity if it does not withdraw the food.
The Food and Drug Administration (FDA) today announced that it is seeking a permanent injunction against Worldwide Fish & Seafood, Inc. (Worldwide Fish), Suzanne Weinstein, its president and owner, and Timothy A. Lauer, its general manager. Worldwide Fish does business as Coastal Seafood, a seafood processor located at 2330 Minnehaha Avenue, in Minneapolis, Minnesota. The firm distributes seafood products to restaurants in Wisconsin, Minnesota, Iowa, and North and South Dakota.
An
Looks like it is time for a new system. From the
Richard Raymond, the USDA Undersecretary for Food Safety yesterday addressed food and restaurant industry groups. According to an
The Washington Post reports that it took a book called "The Jungle," a grim assessment of work inside slaughterhouses, plus a campaign by labor unions, medical professionals and consumer groups, to pressure Congress to pass the Pure Food and Drug Act and the Meat Inspection Act on the same day in 1906.
Per an FDA News Release, there is no doubt that you, the state, local, or tribal health inspector, play a significant role in reducing foodborne illness in your jurisdiction, yet your job can be overwhelming at times due to diminishing resources, increasing workload with limited staff, and growing liability. Many of you are continually forced to reassess your priorities due to increased media attention on food safety, threats from emerging pathogens, and food security, while being challenged to do more with less while maintaining your professional integrity.
A recent Knight-Ridder Tribune editorial said when consumers reach for a package of meat at the supermarket, they shouldn't have to wonder whether the product they're about to take home and cook for their families has been treated to keep it looking fresh. Especially if it isn't.
Per an FDA Media Release the U.S. Food and Drug Administration (FDA) is seeking a permanent injunction against Pacific Shellfish, Inc., a seafood processor located at 5040 Cass Street in San Diego California, and Judd J. Brown, its President. An injunction is a court order to stop a firm from manufacturing, distributing, processing, or shipping a product. The government's complaint, filed on January 24, 2006 by the U.S. Department of Justice in the U.S. District Court for the Southern District of California, charges the defendants with violating the Federal Food, Drug, and Cosmetic Act by permitting ready-to-eat fish held and processed in Pacific Shellfish's facility to become contaminated.
Cindy Skrzycki of the Washington Post reports that after years of trying to sort out who should regulate such culinary delights as the bagel dog, the Food and Drug Administration and the Agriculture Department may be coming to a resolution.
Anna Wilde Mathews and Zachary Goldfarb of the Wall Street Journal report that fearing that the animal drug Baytril -- used to fight infections in chickens -- could pose health risks to humans, the Food and Drug Administration decided to ban its use in poultry.